Xilio Therapeutics to Present at Guggenheim Nantucket

WALTHAM, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective...

Related Keywords

Julissa Viana ,Myles Clouston ,Xilio Therapeutics Inc ,Twitter ,Corporate Communications ,Linkedin Xilio Therapeutics Inc ,Nasdaq ,Guggenheim Nantucket Therapeutics Conference ,Xilio Therapeutics ,Investor Inquiries ,Media Inquiries ,Nasdaq Xlo ,Nc ,